Xonotiv

company

About

Xonotiv develops a prosthetic knee that will improve amputee mobility and safety while also allowing robots to walk like humans.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$224.54K
Industries
Health Care,Robotics,Therapeutics
Founded date
Jan 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

Xonotiv develops a prosthetic knee that will improve amputee mobility and safety while also allowing robots to walk like humans. The company's headquarters are in Auburn, Washington.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.21M
Xonotiv has raised a total of $1.21M in funding over 2 rounds. Their latest funding was raised on Sep 14, 2020 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 14, 2020 Grant $0.98M 1 National Science Foundation Detail
Jun 25, 2018 Grant $224.54K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Xonotiv is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant